Runx1 Runx1t1 Aml1 Eto T821 Qualitative Test
Introduction
The Runx1 Runx1t1 Aml1 Eto T821 Qualitative test is a pivotal diagnostic tool in the field of genetics, specifically tailored for identifying mutations associated with acute myeloid leukemia (AML). Understanding these genetic markers is essential for determining the most effective treatment plans for patients diagnosed with this type of cancer.
What the Test Measures
This test detects the presence of the RUNX1-RUNX1T1 fusion gene, which is a specific genetic alteration linked to acute myeloid leukemia. By identifying this mutation, healthcare providers can better understand the nature of the leukemia and its potential response to treatment.
Who Should Consider This Test
Individuals who exhibit symptoms of acute myeloid leukemia, such as unexplained fatigue, frequent infections, or easy bruising, should consider this test. Additionally, those with a family history of genetic disorders or who are at risk due to previous medical conditions may also benefit from this test.
Benefits of Taking the Test
- Early detection of genetic mutations associated with AML.
- Informed decision-making regarding treatment options.
- Personalized treatment plans based on genetic findings.
- Potential for improved patient outcomes through targeted therapies.
Understanding Your Results
Results from the Runx1 Runx1t1 Aml1 Eto T821 Qualitative test will indicate whether the RUNX1-RUNX1T1 fusion gene is present. A positive result may suggest a specific type of AML, guiding your healthcare provider in crafting a tailored treatment strategy. It is crucial to discuss your results with a qualified healthcare professional who can provide context and advice based on your individual health status.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Runx1 Runx1t1 Aml1 Eto T821 Qualitative | 90,000 NGN | 120,000 NGN |
Booking Your Test
To schedule your Runx1 Runx1t1 Aml1 Eto T821 Qualitative test, please contact us at +2348077798758 or visit our website to book an appointment. Our team is here to assist you with any questions and ensure you receive the best care possible.
Pre-Test Instructions
The Runx1-RUNX1T1 (AML1- ETO) t(8;21) Qualitative test requires a doctor’s prescription. Note that this prescription is not applicable for surgery and pregnancy cases, or for individuals planning to travel abroad.
Sample Type and Turnaround Time
The sample for this test can be obtained from bone marrow or peripheral blood. It is essential to transport the sample immediately to ensure accurate results. The turnaround time for results is typically between 3 to 4 days.
